From: Substance use and HIV stage at entry into care among people with HIV
Substance | OR | P-value | 95% CI | RR | P-value | 95% CI |
---|---|---|---|---|---|---|
Male, Not MSM (ref. Female) | 0.68 | < 0.01 | 0.54–0.85 | 0.86 | 0.01 | 0.79–0.94 |
MSM | 1.33 | < 0.01 | 1.14–1.56 | 1.12 | < 0.01 | 1.05–1.19 |
Age | 0.99 | 0.01 | 0.98–0.99 | 0.99 | 0.01 | 0.99–0.99 |
Race/ethnicity (ref. Non-Hispanic White) | ||||||
 Non-Hispanic Black | 0.80 | 0.01 | 0.67–0.94 | 0.92 | 0.01 | 0.86–0.98 |
 Hispanic | 0.79 | 0.01 | 0.66–0.95 | 0.92 | 0.02 | 0.86–0.98 |
Current depressive symptoms (PHQ-9 Score) | 0.96 | 0.11 | 0.90–1.01 | 0.98 | 0.12 | 0.97–1.0 |
Mental Health Diagnosis (ref. No Mental Health Diagnosis) | ||||||
 Depression and/or Anxiety | 1.26 | < 0.01 | 1.09–1.46 | 1.09 | < 0.01 | 1.03–1.15 |
 Any psychotic, bipolar, or personality disorder | 1.42 | 0.01 | 1.10–1.82 | 1.13 | < 0.01 | 1.04–1.22 |